多发性硬化的治疗  

New advancement in the treatment of multiple sclerosis

作　　者：肖剑平[1] 肖志恒[1] 朱沂[1] 

机构地区：[1]新疆维吾尔自治区人民医院神经内科,乌鲁木齐830002

出　　处：《中华神经医学杂志》2005年第1期106-108,共3页Chinese Journal of Neuromedicine

摘　　要：多发性硬化的免疫抑制与免疫调节治疗在一定程度上改变了多发性硬化的长期病程。目前有针对复发-缓解型,继发-进展型,与进展-复发型多发硬化症的治疗方案。本文回顾了近年研究治疗多发性硬化的药物。Immunosuppressive and immunomodulatory therapies have been shown to alter to some extent the long-term course of multiple sclerosis (MS). Therapies are currently available for relapsing-remitting MS, secondary progressive MS and progressive relapsing MS. This paper reviews the therapeutic agents that have been studied to treat MS in recent years.

关 键 词：免疫调节治疗 多发性硬化 复发型 硬化症 治疗方案 改变 病程 继发 免疫抑制 缓解 

分 类 号：R744.51[医药卫生—神经病学与精神病学] R735.7[医药卫生—临床医学]